肝癌免疫治疗中的两个里程碑研究
Tim F Greten1,2, Cecilia Monge1
1Gastrointestinal Malignancies Section, Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Institutes of Health, National Cancer Institute, Bethesda, MD.
NEJM evidence
|February 6, 2024
概括
免疫疗法为无法切除的肝癌提供了新的希望. 新型治疗方法显示,胆道癌和肝细胞癌患者的生存率有所改善.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
背景情况:
- 无法切除的肝癌,包括胆道癌 (BTC) 和肝细胞癌 (HCC),治疗选择有限.
- 免疫疗法的出现彻底改变了各种恶性瘤的癌症治疗.
- 本期NEJM证据强调了两个关键试验,探索这些肝癌的新型免疫疗法方案.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
760
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526